A Virtual Reality Tour of Inflammatory Bowel Diseases and their Current and Emerging Therapeutic Options
Meenakshi Bewtra, MD, MPH
Assistant Professor of Epidemiology in Biostatistics and Epidemiology
Assistant Professor of Medicine
Hospital of the University of Pennsylvania
Gary R. Lichtenstein, MD, FACP, FACG, AGAF
Professor of Medicine
Raymond and Ruth Perelman School of Medicine
Director, Center for Inflammatory Bowel Disease
Department of Medicine
Division of Gastroenterology
University of Pennsylvania
This case-based enduring activity will cover the diagnosis, treatment, and management of patients with Inflammatory Bowel Diseases (IBD).
This activity is designed to meet the educational needs of gastroenterologists, nurse practitioners, nurses, and other physicians who treat patients with IBD.
Upon completion of the program, attendees should be able to:
- Describe dysfunctional immunologic factors and pathways of clinical importance for IBD therapy.
- Review the novel mechanisms of action and clinical data of emerging IBD treatments, and their safety and efficacy in treatment-refractory patients.
- Describe best practices for assessing IBD patients’ treatment needs, as well as the potential benefits offered by a multidisciplinary approach to IBD care.
- Evaluate real-world data on IBD care quality and treatment practices.
ACCREDITATION AND DESIGNATION STATEMENTS
Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
Med Learning Group designates this online activity for a maximum of 1.25 AMA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the online activity.
Nursing Credit Information
Purpose: This program would be beneficial for nurses involved in the care of patients with IBD. Credits: 1.25 ANCC Contact Hour(s)
Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 1.25 contact hour(s) of continuing nursing education of RNs and APNs.
DISCLOSURE POLICY STATEMENT
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.
DISCLOSURE OF CONFLICTS OF INTEREST
Dr. Bewtra has received research grants from GSK and Takeda; has been a consultant for AbbVie and Janssen; and a CME speaker for CME speaker, Imedex, RMEI, and Vindico.
Dr. Lichtenstein has consulted for Abbvie, CellCeutrix, Celgene, Ferring, Gilead, Janssen Orthobiotech, Luitpold /American Regent, Pfizer Pharmaceuticals, Prometheus Laboratories, Inc., Romark, Salix Pharmaceuticals/Valeant, Shire Pharmaceuticals, Takeda, and UCB; received research funding from Celgene, Janssen Orthobiotech, Salix Pharmaceuticals/Valeant, Shire Pharmaceuticals, and UCB; honorarium as Editor from Clinical Advances in Gastroenterology, Gastro-Hep Communications, and Springer Science and Business Media; honorarium as Associate Editor of American Journal of Gastroenterology from American College of Gastroenterology; has participated in CME for Luitpold / American Regent, Merck, and Romack; has received funding to University of PA (IBD Fellow Education) from Janssen Orthobiotech, Pfizer Pharmaceuticals, and Takeda; has received author honorarium from McMahon Publishing and Up-To-Date; and has received book royalties from SLACK, Inc.
The independent reviewers, staff, planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests:
CME Content Review
The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.
CNE Content Review
The content of this activity was peer reviewed by a nurse reviewer.
The reviewer of this activity has nothing to disclose
Staff, Planners and Managers
Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
Brianna Hanson, Outcomes and Accreditation Manager for Med Learning Group has nothing to disclose.
Chris Drury, MA, MA, Medical Director, Scientific and Medical Services for Med Learning Group has nothing to disclose.
Lisa Dorin, Senior Program Manager for Med Learning Group has nothing to disclose.
DISCLOSURE OF UNLABELED USE
Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.
METHOD OF PARTICIPATION
There are no fees for participating and receiving CME credit for this enduring activity. To receive CME/CNE credit participants must:
1. Read the CME/CNE information and faculty disclosures.
2. Participate in the online activity.
3. Submit the evaluation form to Med Learning Group.
Participants will receive their certificate as a downloadable file.
Med Learning Group makes every effort to develop CME activities that are scientifically based.
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
For CME questions, please contact Med Learning Group at email@example.com
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement
information at http://medlearninggroup.com/privacy‐policy/
RELEASE DATE: February 22, 2019
EXPIRATION DATE: February 22, 2020
Copyright © 2019 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.